NIH R01 · 2025
Testing effects of cash transfers on biological aging and risk for Alzheimer's Disease
Alzheimer's Disease (AD) and AD-Related Disorders (AD/ADRD) are significantly increasing in resource-limited areas, where improved nutrition and decreased infectious disease mortality are enabling population aging. Simultaneously, enduring elevated levels of early-life adversity and adult hardship accelerates the development of aging-related diseases like AD/ADRD. Interventions are needed to reduce disease burden and increase healthy lifespan. Cash transfer programs are proven to reduce mortality in these settings. However, their impact on risk for chronic diseases of aging remains unclear. We propose a novel method to address this knowledge gap: epigenetic clock analysis of the pace and…
From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.